A PRACTICAL PREDICTION MODEL FOR OVERALL SURVIVAL FROM STAGE III LUNG CANCER

被引：0
|
作者：
Oberije, C. [1 ]
Houben, R. [1 ]
De Ruysscher, D. [1 ]
Dingemans, A. M. [2 ]
Bootsma, G. [3 ]
Geraedts, W. [4 ]
Pitz, C. [5 ]
Lunde, R. [5 ]
Lambin, P. [1 ]
机构：
[1] Univ Maastricht, GROW, Sch Oncol & Dev Biol, Maastricht Radiat Oncol MAASTRO,Dept Radiotherapy, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Lung Dis, Maastricht, Netherlands
[3] Atrium Med Ctr, Dept Lung Dis, Heerlen, Netherlands
[4] Orbis Med Ctr, Dept Lung Dis, Sittard, Netherlands
[5] Laurentius Hosp, Dept Lung Dis, Roermond, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2011年 / 99卷
关键词：
D O I：
10.1016/S0167-8140(11)70396-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [21] Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
    Komaki, Ritsuko
    Allen, Pamela K.
    Wei, Xiong
    Blumenschein, George R.
    Tang, Ximing
    Lee, J. Jack
    Welsh, James W.
    Wistuba, Ignacio I.
    Liu, Diane D.
    Hong, Waun Ki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 317 - 324
  • [22] A deep learning approach for overall survival prediction in lung cancer with missing values
    Caruso, Camillo Maria
    Guarrasi, Valerio
    Ramella, Sara
    Soda, Paolo
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2024, 254
  • [23] CORRELATION OF PREDOMINANT HISTOLOGIC SUBTYPE, MUTATION STATUS AND OVERALL SURVIVAL IN STAGE III LUNG ADENOCARCINOMA
    Russell, Prudence A.
    Barnett, Stephen A.
    Walkiewicz, Marzena
    Wainer, Zoe
    Wright, Gavin M.
    Knight, Simon
    Wynne, Rochelle
    Seevanayagam, Siven
    Gooi, Julian
    Alam, Naveed
    Conron, Matthew
    Williams, Richard A.
    John, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1521 - S1521
  • [24] Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival
    Casal-Mourino, Ana
    Ruano-Ravina, Alberto
    Lorenzo-Gonzalez, Maria
    Rodriguez-Martinez, Angeles
    Giraldo-Osorio, Alexandra
    Varela-Lema, Leonor
    Pereiro-Brea, Tara
    Barros-Dios, Juan Miguel
    Valdes-Cuadrado, Luis
    Perez-Rios, Monica
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 506 - 518
  • [25] THE EFFECT OF RADIATION DOSE AND CHEMOTHERAPY ON OVERALL SURVIVAL IN 237 PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER
    Wang, Li
    Correa, Candace R.
    Zhao, Lujun
    Hayman, James
    Kalemkerian, Gregory P.
    Lyons, Susan
    Cease, Kimp
    Brenner, Dean
    Kong, Feng-Ming
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (05): : 1383 - 1390
  • [26] Effectiveness of multi-disciplinary team management on 5-year overall survival for patients with stage III lung cancer
    Valsecchi, Camilla
    Franza, Andrea
    Bogani, Giorgio
    Rolli, Luigi
    Ferrari, Michele
    Leuzzi, Giovanni
    Stanzi, Alessia
    Sabia, Federica
    Pastorino, Ugo
    Prelaj, Arsela
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08)
  • [27] Interpretable machine learning model for prediction of overall survival in laryngeal cancer
    Alabi, Rasheed Omobolaji
    Almangush, Alhadi
    Elmusrati, Mohammed
    Leivo, Ilmo
    Makitie, Antti A.
    ACTA OTO-LARYNGOLOGICA, 2025, 145 (03) : 256 - 262
  • [28] Impact of Travel Distance to Treatment Institution on Survival from Stage I to III Lung Cancer
    Da Silva, C.
    Werutsky, G.
    Gelatti, A.
    Ruiz Tsukazan, M. T.
    Lenz, G.
    Sgnaolin, V.
    Rosa, M.
    D'Avila, R.
    Nunes Filho, P. R.
    Pacheco, P.
    Figueiredo Pinto, J.
    Rios, J.
    Sostruznik, M. H.
    Zaffaroni, F.
    Poisl Fay, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2355 - S2356
  • [29] Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC Study
    Ouwens, Mario
    Darilay, Annie
    Zhang, Yiduo
    Mukhopadhyay, Pralay
    Mann, Helen
    Ryan, James
    Dennis, Phillip A.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2021, 95
  • [30] Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
    Mitchell, P.
    Thatcher, N.
    Socinski, M. A.
    Wasilewska-Tesluk, E.
    Horwood, K.
    Szczesna, A.
    Martin, C.
    Ragulin, Y.
    Zukin, M.
    Helwig, C.
    Falk, M.
    Butts, C.
    Shepherd, F. A.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1134 - 1142
12345